Ads

Postdoctoral Research Associate, Brindle Laboratory

A new openingpostdoctoral position in pharmacy is available at University of Cambridge, UK. This position is available for 5 years in the first instance. Applicants should apply before October 14, 2018.

Europe’s top cancer charity, Cancer Research UK, has combined with the University of Cambridge to create the world class Cambridge Institute (CRUK CI) situated on the Cambridge Biomedical Campus. The Institute’s research ranges from basic cancer biology through translational research to clinical application. The Institute currently houses 22 research groups and 12 state-of-the-art research facilities.

We are seeking a Postdoctoral Scientist to engage in radionuclide imaging (PET/SPECT) research in the CRUK CI.

The purpose of the role will be to support and collaborate with research groups working with radionuclide imaging and to run research projects that contribute to the aims of the Brindle laboratory and the wider Institute. The role will be responsible for developing and implementing new PET/SPECT radiotracers for translational research, which will involve liaison with the radiochemistry facilities in the Wolfson Brain Imaging Centre and the Radiopharmacy in Addenbrooke’s Hospital. The role holder will also act as one of the Radiation Protection Supervisors for the CI.
- Involvement in PET and SPECT studies including provision of radiochemical, scientific and technical input into study design, interpretation of results and publications.
- Selection, design and development of novel PET/SPECT radiotracers for pre-clinical imaging research programmes.
- Promoting collaborations both within the CI and outside, including those with pharmaceutical companies.
- Radioprotection coverage in the pre-clinical imaging facilities in the CI.
- Advising users of the facility on appropriate methodology and use of radiotracers for new studies.
- Liaise with instrument manufacturers to ensure maintenance and prompt repair of faults of the radionuclide imaging and CT equipment in the CI.
- Constructing or purchasing equipment as required for new applications.
- Keep abreast of developments in the field.

The ideal candidate will have a PhD in radionuclide imaging research or equivalent and should be able to demonstrate post-doctoral level experience in radionuclide imaging research.

Competence in radioprotection and knowledge of PET/SPECT applications in in-vivo imaging are an essential requirement of the role. Experience of biodistribution studies, development of novel and established PET/SPECT radiotracers, including selection and design of radiotracers, is important. The successful candidate will be a clear communicator with excellent oral and written communication skills.

Read more about the CI’s imaging facilities here: http://www.cambridgecancer.org.uk/core-facilities

Fixed-term: The funds for this post are available for 5 years in the first instance.

Once an offer of employment has been accepted, the successful candidate will be required to undergo a security check.

The closing date is 14th October 2018, with the interview date TBC.

Please ensure that you upload a covering letter and CV in the Upload section of the online application. If you upload any additional documents which have not been requested, we will not be able to consider these as part of your application.

Please include details of your referees, including email address and phone number, one of which must be your most recent line manager.


Summary:

Get latest scholarships via your email! It's free!
Your information will never be shared.
You can unsubscribe any time.
Copyright © 2015 HuntScholarship.com. All Right Reserved.